Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05729516 · ClinicalTrials.gov registry record · NA

The Hope App Study

A NA study of Type 2 Diabetes, sponsored by See Yourself Health.

Active
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05729516: Active NA study of Type 2 Diabetes, sponsored by See Yourself Health.

NCT05729516 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by See Yourself Health. The registered enrollment target is 150 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05729516, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by See Yourself Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This research study will test how a computer program (called the Hope App) teaches diabetes care skills for older adults with diabetes. The study will compare those who receive diabetes education (10 educational modules and monthly health coaching) through the research program with those who receive care as usual.

Conditions Studied

Interventions

  • BEHAVIORAL Hope App immersive learning and telehealth platform

Study Locations (1)

Massachusetts

  • See Yourself Health - Beverly

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-05-24
Est. Completion 2025-08
Phase NA

Sponsor

See Yourself Health

1 total trials

What the Registry Record Tells You About NCT05729516

The ClinicalTrials.gov registry entry for NCT05729516 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (86% lower). The listed sponsor is See Yourself Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Hope App immersive learning and telehealth platform is the first listed.

NCT05729516 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05729516 about?

NCT05729516 is a clinical study titled "The Hope App Study". This research study will test how a computer program (called the Hope App) teaches diabetes care skills for older adults with diabetes. The study will compare those who receive diabetes education (10 educational modules and monthly health coaching) through the research program with those who receive...

What is the current status of trial NCT05729516?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-05-24. Estimated completion is 2025-08.

What conditions does trial NCT05729516 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05729516?

The interventions under investigation include: Hope App immersive learning and telehealth platform (BEHAVIORAL).

Who is sponsoring clinical trial NCT05729516?

This trial is sponsored by See Yourself Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05729516 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.